Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 8 reviews

538%
425%
338%
20%
10%
Hadi Winanda
Reviews 1

The experience I had with Cinfa Biotech was excellent. The quality of their products and services is top-notch. The team was very knowledgeable and provided me with all the information I needed. I would highly recommend Cinfa Biotech to anyone looking for a reliable and trustworthy company.

Matthew Ragland
Reviews 1

I recently purchased some products from a biotech company and I was very satisfied with the quality and effectiveness of the products. The company provided great customer service and answered all my questions promptly. I would definitely recommend them to others!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Cinfa Biotech

Cinfa Biotech was created in 2013 as part of the Spanish Cinfa Group. The company conduct biosimilars development and manufacturing exclusively in Europe. Highest European quality standards based on strict guidelines and their specialist know-how are the key to their success in the global biosimilars market. They currently have two product candidates in development including: Cinfa Biotech’s lead product candidate, pegfilgrastim, a biosimilar version of Neulasta® (INN: pegfilgrastim) to treat chemotherapy-induced neutropenia. Pegfilgrastim, a granulocyte colony-stimulating factor (G-CSF) receptor agonist, is used to stimulate bone marrow to produce more neutrophils in order to decrease the incidence of infection in patients undergoing chemotherapy.